Skip to main content
. 2020 Jan 3;69(1):147–157. doi: 10.1007/s00262-019-02449-y

Table 2.

Changes of lymphocyte subsets during chemotherapy

Total population
Before chemotherapy After chemotherapy P value Control group P-value (patients vs. control)
(a) B lymphocytes
B Lymphocytes 0.076 [0.039; 0.160] 0.049 [0.024; 0.106] 0.001 0.230 [0.173; 0.270] 0.000
Naive 0.049 [0.021; 0.111] 0.025 [0.013; 0.056] 0.001 0.115 [0.087; 0.189] 0.002
Memory 0.003 [0.002; 0.008] 0.002 [0.000; 0.004] 0.001 0.005 [0.004; 0.065] n.s.
Class switch 0.011 [0.006; 0.020] 0.006 [0.003; 0.012] 0.011 0.030 [0.023; 0.042] 0.001
Transitory 0.002 [0.000; 0.005] 0.000 [0.000; 0.002] n.s. 0.006 [0.003; 0.006] 0.005
(b) CD8 + T lymphocytes
CD8 + Lymphocytes 0.214 [0.122; 0.374] 0.233 [0.120; 0.319] n.s. 0.275 [0.212; 0.415] n.s.
CD4 + CD8+ 0.005 [0.002; 0.013] 0.003 [0.002; 0.012] n.s. 0.006 [0.001; 0.009] n.s.
Memory 0.059 [0.040; 0.126] 0.086 [0.034; 0.128] n.s. 0.101 [0.051; 0.137] n.s.
Central memory 0.028 [0.015; 0.062] 0.025 [0.016; 0.048] n.s. 0.004 [0.002; 0.014] 0.000
Naive 0.043 [0.017; 0.091] 0.034 [0.016; 0.066] n.s. 0.005 [0.002; 0.015] 0.001
Effector memory 0.054 [0.037; 0.110] 0.067 [0.030; 0.119] n.s. 0.121 [0.074; 0.172] 0.007
EMRA 0.050 [0.023; 0.110] 0.068 [0.031; 0.120] n.s. 0.140 [0.106; 0.187] 0.003
Early 0.082 [0.048; 0.168] 0.078 [0.052; 0.174] n.s. 0.176 [0.087; 0.262] n.s.
Intermediate 0.010 [0.006; 0.185] 0.014 [0.008; 0.030] n.s. 0.026 [0.013; 0.045] 0.001
Late 0.044 [0.024; 0.117] 0.054 [0.024; 0.126] n.s. 0.081 [0.033; 0.151] n.s.
Exhausted 0.055 [0.034; 0.107] 0.068 [0.036; 0.118] n.s. 0.140 [0.078; 0.266] 0.006
Terminal effector 0.033 [0.021; 0.114] 0.037 [0.015; 0.101] n.s. 0.026 [0.013; 0.092] n.s.
HLA-DR+ 0.066 [0.031; 0.131] 0.076 [0.032; 0.153] n.s. 0.007 [0.003; 0.025] 0.000
CD69+ 0.037 [0.018; 0.065] 0.043 [0.022; 0.773] n.s. 0.054 [0.036; 0.070] n.s.
Regulatory 0.000 [0.000; 0.002] 0.001 [0.000; 0.002] n.s. 0.000 [0.000; 0.001] n.s.
CD25+ 0.001 [0.000; 0.001] 0.001 [0.000; 0.001] n.s. 0.000 [0.000; 0.001] n.s.
(c) CD4 + T lymphocytes
CD4 + Lymphocytes 0.587 [0.367; 0.802] 0.443 [0.236; 0.679] n.s. 0.595 [0.442; 1.128] n.s.
Memory 0.317 [0.226; 0.547] 0.301 [0.157; 0.376] n.s. 0.333 [0.258; 0.512] n.s.
Central memory 0.220 [0.141; 0.331] 0.178 [0.103; 0.270] n.s. 0.079 [0.061; 0.193] 0.007
Naive 0.193 [0.065; 0.330] 0.104 [0.035; 0.272] n.s. 0.216 [0.106; 0.365] n.s.
Effector memory 0.119 [0.068; 0.203] 0.099 [0.068; 0.198] n.s. 0.273 [0.200; 0.385] 0.010
EMRA 0.008 [0.002; 0.020] 0.005 [0.002; 0.016] n.s. 0.050 [0.036; 0.088] 0.001
HLA-DR+ 0.058 [0.043; 0.082] 0.046 [0.037; 0.085] n.s. 0.018 [0.008; 0.030] 0.001
CD69+ 0.049 [0.027; 0.117] 0.035 [0.021; 0.071] n.s. 0.034 [0.020; 0.039] n.s.
Th1 0.042 [0.018; 0.069] 0.030 [0.012; 0.060] n.s. 0.025 [0.011; 0.063] n.s.
Th2 0.049 [0.025; 0.091] 0.042 [0.023; 0.076] n.s. 0.040 [0.023; 0.071] n.s.
Th17 0.033 [0.020; 0.054] 0.031 [0.021; 0.050] n.s. 0.049 [0.034; 0.071] n.s.
Regulatory 0.027 [0.015; 0.047] 0.012 [0.010; 0.033] n.s. 0.017 [0.011; 0.026] n.s.
CD25+ 0.008 [0.005; 0.014] 0.009 [0.004; 0.014] n.s. 0.003 [0.001; 0.003] 0.000
CD4/CD8 2.403 [1.685; 3.842] 1.824 [1.328; 3.482] n.s. 2.276 [1.641; 3.390] n.s.
(d) NK cells
NK Cells 0.131 [0.093; 0.240] 0.131 [0.073; 0.232] n.s. 0.240 [0.153; 0.463] n.s.
CD56 + CD16+ 0.036 [0.017; 0.083] 0.043 [0.012; 0.072] n.s. 0.160 [0.108; 0.255] 0.000
CD56bright CD16dim 0.003 [0.001; 0.007] 0.003 [0.001; 0.006] n.s. 0.014 [0.008; 0.027] 0.000
CD56dim CD16bright 0.004 [0.002; 0.018] 0.006 [0.002; 0.010] n.s. 0.019 [0.015; 0.026] 0.020
NK/T 0.046 [0.025; 0.098] 0.053 [0.021; 0.083] n.s. 0.005 [0.020; 0.135] n.s.

(a) B lymphocytes (b) CD8 + T lymphocytes (c) CD4 + T lymphocytes (d) NK cells. Numbers are median values/ml and interquartile ranges in square brackets. P < 0.022 = significant

n.s not significant, EMRA effector memory RA+